MBG/PLGA composite microspheres with prolonged drug release.

Mesoporous bioactive glass (MBG) and composite microspheres with MBG particles embedded in biodegradable poly(D,L-lactide-co-glycolide) (PLGA) matrix have been prepared and used to load gentamicin (GS). The in vitro drug release experiments from both MBG and composite microspheres were conducted in distilled water and phosphate buffered saline (PBS) solution at 37 degrees C for more than 30 days. In both water and PBS, GS release from the MBG was very fast with about 60 wt % of the loaded drug released in the first 24 h, and more than 80 wt % released in two days. MBG/PLGA composite microspheres showed an initial release of about 33 wt % in the first day, and 48 wt % in 2 days, and a subsequent sustained release lasting for more than 4 weeks in PBS. MBG/PLGA composite microspheres may be used as an alternative drug release system, especially as a bone void filler for bone repair due to their combined advantages of sustained release of antibiotics and apatite-forming ability.

[1]  A. Yamazaki,et al.  Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis. , 2008, Biomaterials.

[2]  姜鹏,et al.  Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated approach , 2007 .

[3]  M. Elorza,et al.  Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. , 2007, Biomaterials.

[4]  常江.  Well-ordered mesoporous bioactive glasses(MBG):A promising bioactive drug delivery system , 2006 .

[5]  J. Xue,et al.  Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[6]  T. Kissel,et al.  Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. , 2006, Biomaterials.

[7]  D. Zhao,et al.  The in-vitro bioactivity of mesoporous bioactive glasses. , 2006, Biomaterials.

[8]  María Vallet-Regí,et al.  Ordered Mesoporous Bioactive Glasses for Bone Tissue Regeneration , 2006 .

[9]  D. W. Pack,et al.  Use of thermodynamic parameters for design of double-walled microsphere fabrication methods. , 2006, Biomaterials.

[10]  Duu-Jong Lee,et al.  In vitro and in vivo release of gentamicin from biodegradable discs. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[11]  M. Bengisu,et al.  Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[12]  Yongsheng Li,et al.  Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface , 2005 .

[13]  J. V. van Horn,et al.  The influence of ultrasound on the release of gentamicin from antibiotic-loaded acrylic beads and bone cements. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[14]  Hyoun‐Ee Kim,et al.  Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[15]  M. Vallet‐Regí,et al.  Tissue regeneration: A new property of mesoporous materials , 2005 .

[16]  Shih-Jung Liu,et al.  A novel solvent-free method for the manufacture of biodegradable antibiotic-capsules for a long-term drug release using compression sintering and ultrasonic welding techniques. , 2005, Biomaterials.

[17]  Duu-Jong Lee,et al.  Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Xufeng Zhou,et al.  Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. , 2004, Angewandte Chemie.

[19]  Jonathan C Knowles,et al.  Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[20]  J. Xue,et al.  PLGA/mesoporous silica hybrid structure for controlled drug release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[21]  M. Vallet‐Regí,et al.  Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Balaji Narasimhan,et al.  Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[23]  W. Wallace,et al.  Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery. , 2004, Biomaterials.

[24]  R. Sinisterra,et al.  Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with beta-cyclodextrin. , 2004, Biomaterials.

[25]  K. P. Rao,et al.  Preparation, characterization, and in vitro release of gentamicin from coralline hydroxyapatite-alginate composite microspheres. , 2003, Journal of biomedical materials research. Part A.

[26]  S. Feng,et al.  Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[27]  S. Radin,et al.  In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. , 2002, Biomaterials.

[28]  M. Wang,et al.  Production and evaluation of biodegradable composites based on PHB-PHV copolymer. , 2002, Biomaterials.

[29]  M. Jokinen,et al.  Effect of synthesis parameters of the sol-gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine. , 2002, Biomaterials.

[30]  W. Friess,et al.  Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles. , 2002, Journal of pharmaceutical sciences.

[31]  M. Vallet‐Regí,et al.  Bioactivity in glass/PMMA composites used as drug delivery system. , 2001, Biomaterials.

[32]  D. Pichora,et al.  Biodegradable Controlled Antibiotic Release Devices for Osteomyelitis: Optimization of Release Properties , 1994, The Journal of pharmacy and pharmacology.

[33]  D. Robinson,et al.  Comparison of new and existing spectrophotometric methods for the analysis of tobramycin and other aminoglycosides. , 1990, Journal of pharmaceutical sciences.

[34]  K. Unger,et al.  The use of porous and surface modified silicas as drug delivery and stabilizing agents , 1983 .

[35]  Larry L. Hench,et al.  Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .